Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX®) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective

Objectives To evaluate the cost effectiveness of onabotulinumtoxinA (BOTOX ® , 200 units [200 U]) for the management of urinary incontinence (UI) in adults with neurogenic detrusor overactivity (NDO) due to subcervical spinal cord injury or multiple sclerosis that is not adequately managed with anti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PharmacoEconomics 2015-04, Vol.33 (4), p.381-393
Hauptverfasser: Hamid, Rizwan, Loveman, Clara, Millen, Jim, Globe, Denise, Corbell, Catherine, Colayco, Danielle, Stanisic, Sanja, Gultyaev, Dmitry
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!